Intelligence Hub
Market analytics and operational performance indicators
Insider Trading - December 16, 2025
Director Saintil sold 15,000 shares ($975K) at $65.
Brief
Merline Saintil, Director at Rocket Lab USA, sold 15,000 shares of common stock on 12/12/2025 at $65 per share, totaling ~$975K. This reduced her direct holdings to 398,529 shares. The discretionary sale (no 10b5-1 indicated) is a moderate bearish signal.
Detailed Brief
Merline Saintil, a Director of Rocket Lab USA Inc. (RKLB), reported selling 15,000 shares of common stock on December 12, 2025, via an open-market transaction (Transaction Code: S) at a price of $65 per share, for a total value of approximately $975,000. Following the transaction, she beneficially owns 398,529 shares directly, with no indirect ownership reported in Table II. The Form 4 does not check the box indicating the sale was pursuant to a Rule 10b5-1 trading plan, suggesting it was discretionary. No derivative transactions were reported. This appears to be an isolated sale without context on prior patterns, timing relative to earnings, or price extremes from this filing alone.
Key Telemetry
- • Sold 15,000 shares (~3.8% of post-sale direct holdings of 398,529 shares)
- • Discretionary open-market sale; no 10b5-1 plan indicated
- • Value: $975K at $65/share; no price context (e.g., 52-week high/low) provided
- • Filed 12/16/2025 shortly after 12/12/2025 transaction; no catalysts noted
Impact Vector
The discretionary sale by Director Saintil signals moderate bearish confidence, as she reduced her position amid high share price, potentially locking in gains. The small relative size limits bearish intensity, but lacks bullish counter-signal.